Coffee Consumption and Arrhythmia Risk: What’s the Link?
Each additional cup of habitual coffee consumed reduced the risk of incident arrhythmia by 3%.
CHF and Arrhythmias
Heart Failure With Mildly Reduced Ejection Fraction: Treatment Options Explored
Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.
Empagliflozin Cuts Risk of Hospitalization, Death in HFpEF Patients
The phase 3 EMPEROR-Preserved trial included 5988 adult patients with heart failure with preserved ejection fraction, with and without diabetes.
New-Onset SVT Following Colonoscopy Bowel Prep Explored in Case Series
A significant percentage of affected patients were observed to have dilated atria and left ventricular hypertrophy.
Gene Therapy Gets Orphan Drug Status for Genetic Hypertrophic Cardiomyopathy
TN-201 is a potentially curative, one-time, AAV-based gene therapy to address genetic hypertrophic cardiomyopathy caused by MYBPC3 gene mutations.
FDA: Consumer Electronics May Impact Implanted Medical Devices
The FDA is advising patients with implanted medical devices to consider keeping consumer electronics at least 6 inches away from the implanted medical device.
Class I Recall Issued for HeartWare HVAD System Instructions for Use, Patient Manual
The HeartWare HVAD System is indicated for hemodynamic support in patients with advanced, refractory left ventricular heart failure; either as a bridge to cardiac transplantation, myocardial recovery, or as destination therapy in patients for whom subsequent transplantation is not planned.
SGLT2 Inhibitor Use Linked to Reduced Risk of Atrial Arrhythmias in T2DM Patients
This meta-analysis aimed to determine the association between SGLT2i use and arrhythmias in patients with T2DM or HF.
- Loading...
Loading...
Loading... 
Loading...